A--PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE MO
ID: 75N94024R00003Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NICHDBETHESDA, MD, 20817, USA

PSC

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH (AJ11)

Original Source

https://sam.gov/opp/f9b2af5fa11b43c99a4b66ab5b097b7b/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a contract focused on preclinical medications screening in models of Alcohol Use Disorder (AUD). The objective of this procurement is to conduct blind testing of compounds supplied by developers using mouse models, with the contractor responsible for generating analyses and reports throughout the project. This initiative is crucial for advancing research in alcohol use disorder treatments and ensuring compliance with NIH policies on reproducibility and animal welfare. Proposals are due by September 18, 2024, with the contract period commencing on December 1, 2024, and extending through November 30, 2031. Interested parties can contact Lisa Schaupp at lisa.schaupp@nih.gov or 301-827-8135 for further information.

    Point(s) of Contact
    SCHAUPP, LISA L
    (301) 827-8135
    lisa.schaupp@nih.gov
    Files
    Title
    Posted
    Amend_01_Att_01_02_03_RFP_75N94024R00003_8_23_24_0001.pdf
    Amendment 01 to RFP 75N94024R00003 outlines special contract requirements regarding information and physical security for government-owned/contractor-operated (GOCO) and contractor-owned/contractor-operated (COCO) systems. Key provisions include compliance with federal security regulations, including the HHS Information Security and Privacy Policy and NIST guidelines. Contractors must obtain a valid Authority to Operate (ATO) within three months post-award, and submit a System Security Plan (SSP) and Plan of Action and Milestones (POA&M) detailing security controls and vulnerability management. Furthermore, contractors must ensure continuous monitoring of IT assets, apply secure coding practices, and facilitate government access for security assessments. The document specifies guidelines for end-of-life software, use of secured devices, data rights, and cybersecurity supply chain risk management. Additionally, contractors are mandated to comply with Section 508 of the Rehabilitation Act regarding electronic accessibility of deliverables. The contract concerns a preclinical testing program for drugs aimed at treating Alcohol Use Disorder and is set to begin on December 1, 2024, lasting 12 months with six options for extension. This RFP emphasizes the government's commitment to upholding stringent security and accessibility standards in conjunction with advancing public health research.
    att_24_links.pdf
    The document is a compilation of attachments and resources related to federal and state/local Request for Proposals (RFPs) for the National Institutes of Health (NIH). It includes various essential components required for proposal submissions, such as guidelines for proposal packaging, intent response sheets, a statement of work for an Indefinite Delivery Indefinite Quantity (IDIQ) contract, and specified reporting requirements and deliverables. Additional key items consist of technical proposal forms, cost summary links, and compliance certifications, along with instructions for invoicing and financial requests. Furthermore, it outlines specific templates for small business subcontracting plans, government property scheduling, and employee suitability investigations. The document emphasizes the necessity of safeguarding non-public information through contractor agreements. Task orders, including statements of work for pre-clinical contract administration and compound testing, are also described. The comprehensive nature of these attachments indicates a structured approach to facilitate proposals, ensuring clarity and adherence to federal guidelines, thereby supporting the government's procurement processes. This intricate framework reinforces the commitment to maintain robustness and transparency in public spending.
    Presolicitation_Notice_75N94024R00003_PreClinical_Dependency_Mice_2.pdf
    SBCX_Industry_Subcontracting_Guide_0002.pdf
    The "HHS Industry User Guide for Subcontracting Plan Reviews" serves as a comprehensive manual for vendors required to submit subcontracting plans to the Department of Health and Human Services (HHS). The document outlines the process for accessing and reviewing subcontracting plans through the SBCX platform, which includes sections for project information, subcontracting goals, documentation, and communication with HHS officials. Vendors are guided to identify the type of subcontracting plan, report eligible subcontracting expenditures, provide necessary goal data, designate a Subcontracting Program Administrator, and detail efforts to include small businesses. They must certify compliance and submit the plan for approval. The evaluation process involves multiple approvers, ensuring thorough oversight. The guide emphasizes the importance of compliance with subcontracting goals within the context of federal and local RFPs, aligning with broader government objectives to engage small businesses in federal contracting opportunities. The document ultimately facilitates a structured approach to subcontracting plan submissions and reviews, ensuring adherence to government standards.
    Sol_75N94024R00003_Amd_0001.pdf
    The document serves as an amendment to solicitation number 75N94024R00003 issued by the National Institute of Child Health (NICHD), detailing modifications to the initial request related to a contract for "Preclinical Medications Screening in Dependence Models of Alcohol Use Disorder." Key updates include the addition of a new section on information security, revisions to Section M.6 for compliance with Section 508 guidelines, and amendments to Attachment 21 to include the necessary Section 508 language. The performance period for the contract is specified from December 1, 2024, to November 30, 2031. In accordance with federal requirements, offers must acknowledge receipt of this amendment to avoid rejection. The document emphasizes adherence to rigorous standards for information security and accessibility, reflecting the government’s commitment to ensuring equitable access to information and services in the procurement process. This amendment is a formal step in the federal contracting process, aligning with guidelines for soliciting offers and modifying existing contracts.
    Sol_75N94024R00003_Amd_0002.pdf
    The document pertains to Amendment 02 of Solicitation No. 75N94024R00003 issued by the National Institute of Child Health (NICHD), part of the National Institutes of Health (NIH). The amendment outlines important procedural guidelines for potential offerors, emphasizing the necessity of acknowledging receipt of the amendment by a specified date to avoid the rejection of offers. The primary focus is on the solicitation titled "Preclinical Medications Screening in Dependence Models of Alcohol Use Disorder," with a performance period set from December 1, 2024, to November 30, 2031. Key changes in this amendment include provisions for submitting written questions to Ms. Sarah Bank by September 4, 2024, and inclusion of a guide for subcontracting plan reviews. It also updates a specific section to incorporate a link for the SBCX Subcontracting Plan Review. The document reinforces the need for compliance with the call for amendments and modifications applicable to governmental contracts, highlighting the importance of clear communication and documentation in federal contract procedures. Overall, it serves as a crucial resource for contractors interested in the mentioned solicitation, facilitating clarity and proper protocol adherence in the submission process.
    Sol_75N94024R00003.pdf
    The National Institutes of Health (NIH) issued a Request for Proposals (RFP) for a contract related to preclinical medication screening in models of Alcohol Use Disorder (AUD). The project aims to conduct blind testing of compounds supplied by developers in mice, with analyses and reports to be generated. Proposals are due by September 18, 2024, and the contract period spans from December 1, 2024, to November 30, 2031. This contract, accessible to various small businesses, outlines estimated costs, payment terms, and specific performance requirements, including adherence to NIH policies on reproducibility, animal welfare, and financial conflicts of interest. The contractor will provide all necessary personnel and resources, submitting regular progress reports and ensuring compliance with federal procurement regulations. Rigorous standards for monitoring and response to conflicts of interest are established, emphasizing the contractor’s accountability for transparent research practices. The successful offeror will engage in a structured process for task orders, ensuring alignment with NIH directives and the overall mission of advancing alcohol research.
    Sources_Sought_75N94024R00003_1.pdf
    Statement_of_Work_dated_2_14_2024_1.pdf
    Similar Opportunities
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP) and federal regulations. This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million over the contract period from September 1, 2025, to May 14, 2031. Interested parties must submit their proposals by December 3, 2024, and can direct inquiries to primary contact Samson Shifaraw at samson.shifaraw@nih.gov or secondary contact Valerie Whipple at valerie.whipple@nih.gov.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Pathology Monitoring of Aged Rodent Colonies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), is seeking proposals for a federal contract titled "Pathology Monitoring of Aged Rodent Colonies." This contract aims to perform clinical evaluations of aged mice and rats from NIA colonies, including health assessments and reporting results to the NIA Contracting Officer Representative (COR). The selected contractor will evaluate between 600 and 1,200 animals annually, conducting various tests and examinations to monitor their health, with a contract period anticipated to begin around March 1, 2025, and lasting for five years. Interested parties should note that the solicitation is expected to be released on November 19, 2024, and may contact Eric McKay at eric.mckay@nih.gov or 301-480-2406 for further information.
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and genomic data for research on psychiatric disorders, thereby facilitating a deeper understanding of the genetic factors involved in mental health. This initiative is vital for advancing both basic and translational research in the field of mental health, ensuring broad access to valuable resources for researchers. Proposals are due by November 21, 2024, and must be submitted electronically via the NIH's eCPS system; interested parties can contact Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research purposes, aimed at advancing the understanding of nervous system disorders. This initiative is critical for enhancing biomedical research by providing well-characterized specimens to researchers, thereby facilitating studies that could lead to improved treatments and interventions. Proposals are due by November 25, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending potentially through multiple option years. Interested vendors should contact Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.
    Clinical Site and Study Monitoring for NIMH Funded Research in Global Settings
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for clinical site and study monitoring services for research funded by the National Institute of Mental Health (NIMH) in global settings. The primary objective of this procurement is to support efforts aimed at reducing mental health disparities, particularly in low and middle-income countries, through rigorous monitoring practices that comply with federal regulations and Good Clinical Practice. This five-year contract, expected to commence on November 25, 2024, has an anticipated budget of up to $2,000,000, with firm-fixed price task orders awarded as needed. Interested parties should direct inquiries to Cassandra Conley at cassandra.conley@nih.gov or Rieka Plugge at rieka.plugge@nih.gov.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    A--To award Indefinite Delivery Indefinite Quantity (IDIQ) Contract for a Biologic
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to fulfill an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the Biological Testing Facility (BTF), which focuses on the preclinical development of contraceptive products. The objective of this procurement is to support the discovery and optimization of anti-fertility agents, ensuring safety and efficacy evaluations that meet regulatory standards for clinical trials, ultimately aiding in the development of high-quality reproductive health products. Interested small businesses must demonstrate their qualifications, including compliance with Good Laboratory Practice and Good Manufacturing Practice, and provide capability statements by November 21, 2024, with the anticipated contract performance period running from September 3, 2025, to September 2, 2032. For further inquiries, interested parties may contact Adelola O. St John at lk202p@nih.gov or call 301-435-6955.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment Development
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), intends to award a sole-source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective is to procure a subject matter expert with extensive experience in neurotechnology and mental health product development, who will provide strategic guidance and oversight for projects aimed at accelerating the translation of innovative medical devices for neurological disorders. This initiative, established in 2019 with a funding allocation of $32 million, seeks to facilitate the development of groundbreaking technologies and ensure their progression to clinical studies by 2027. Interested parties may submit their qualifications by November 8, 2024, to the designated contacts, Tracy Cain and Llakim Dubroff, at the NIH.